Strategic Communications and Marketing News Bureau

Imaging agents light up two cancer biomarkers at once to give more complete picture of tumor

CHAMPAIGN, Ill. — Cancer surgeons may soon have a more complete view of tumors during surgery thanks to new imaging agents that can illuminate multiple biomarkers at once, University of Illinois Urbana-Champaign researchers report. The fluorescent nanoparticles, wrapped in the membranes of red blood cells, target tumors better than current clinically approved dyes and can emit two distinct signals in response to just one beam of surgical light, a feature that could help doctors distinguish tumor borders and identify metastatic cancers. 

The imaging agents can be combined with bioinspired cameras, which the researchers previously developed for real-time diagnosis during surgery, said research group leader Viktor Gruev, an Illinois professor of electrical and computer engineering. In a new study in the journal ACS Nano, the researchers demonstrated their new dual-signal nanoparticles in tumor phantoms – 3D models that mimic the features of tumors and their surroundings – and in live mice. 


Two researchers stand holding vials of cancer imaging agents.

Postdoctoral researcher Indrajit Srivastava, left, and electrical and computer engineering professor Viktor Gruev led a team of researchers developing new cancer imaging agents that can light up two cancer biomarkers when lit by one fluorescent wavelength. 

“If you want to find all the cancer, imaging one biomarker is not enough. It could miss some tumors. If you introduce a second or a third biomarker, the likelihood of removing all cancer cells increases, and the likelihood of a better outcome for the patients increases.” said Gruev, who also is a professor in the Carle Illinois College of Medicine. “Multiple-targeted drugs and imaging agents are a recent trend, and our group is driving the trend hard because we have the camera technology that can image multiple signals at once.”

Traditionally, a surgeon removes a tumor and sends it to a pathologist for assessment, a process that can take hours to days, said Illinois postdoctoral researcher Indrajit Srivastava, the first author of the paper. As research has moved toward real-time diagnostics, several challenges have prevented wide application: Many tumor-targeted imaging agents only minimally reach their tumor targets, instead being quickly cleared from the blood stream and accumulating in the liver, Srivastava said. 

“A few people before us have used nanoparticles coated with red blood cells and found they circulate longer – a few days. We saw the same thing in our mice: The membrane-coated nanoparticles circulated longer in blood, with reduced uptake in the liver. Because they were circulating longer, more of the imaging agents accumulated in the tumors, giving us a stronger fluorescent signal,” Srivastava said. 

An artist's rendering of membrane-wrapped nanoparticles binding to markers on a cancer cell and emitting colored light.

One wavelength of laser light during surgery elicits two distinct signals from the membrane-wrapped nanoparticles, one color for each of the two biomarkers that the nanoparticles target. One is common in earlier stages of cancer, and the other indicates later-stage – and possibly metastatic – cancer. 

The two biomarkers targeted by the new imaging agents include one that is prevalent in early cancer and one that is prevalent in late-stage cancer, which is more likely to be metastatic. The researchers found that the probes were effective at distinguishing cancerous tissue from healthy tissue, as well as distinguishing the two signals from each other.

“This is appealing for surgical application, as it could help determine where exactly to make the cut. Having multiple signals gives a more overall picture of the tumor. And it could tell a surgeon, ‘This may be metastatic, you may want to be more aggressive in your removal.’” Srivastava said.

Only needing one wavelength of laser light to elicit multiple signals is another benefit for surgical applications, as it makes the instrumentation much more compact than those requiring multiple lasers for each needed wavelength, Gruev said. 

The researchers plan to develop more tumor-imaging agents that target multiple markers, and to move forward with further preclinical and clinical studies using their dual-signal dyes with surgical goggles they have developed.

“In this battle for ensuring we remove all the cancer cells during surgery, we need investments both in the imaging camera technology and in the tumor targeting agents,” Gruev said. “This work is helping us better realize and guide the holistic approach that we are taking as we are getting closer and closer to clinical trials.”

The U.S. Congressionally Directed Medical Research Programs, the National Institutes of Health and the National Science Foundation supported this work. Gruev also is affiliated with the department of bioengineering, the Beckman Institute for Advanced Science and Technology and the Cancer Center at Illinois

Editor’s notes: To reach Viktor Gruev, email vgruev@illinois.edu. To reach Indrajit Srivastava, email indrajit@illinois.edu.

The paper “Cell-membrane coated nanoparticles for tumor delineation and qualitative estimation of cancer biomarkers at single wavelength excitation in murine and phantom models” is available online

DOI: 10.1021/acsnano.3c00578

 

Read Next

Health and medicine Dr. Timothy Fan, left, sits in a consulting room with the pet owner. Between them stands the dog, who is looking off toward Fan.

How are veterinarians advancing cancer research in dogs, people?

CHAMPAIGN, Ill. — People are beginning to realize that dogs share a lot more with humans than just their homes and habits. Some spontaneously occurring cancers in dogs are genetically very similar to those in people and respond to treatment in similar ways. This means inventive new treatments in dogs, when effective, may also be […]

Honors From left, individuals awarded the 2025 Campus Awards for Excellence in Public Engagement are Antoinette Burton, director of the Humanities Research Institute; Ariana Mizan, undergraduate student in strategy, innovation and entrepreneurship; Lee Ragsdale, the reentry resource program director for the Education Justice Project; and Ananya Yammanuru, a graduate student in computer science. Photos provided.

Awards recognize excellence in public engagement

The 2025 Campus Awards for Excellence in Public Engagement were recently awarded to faculty, staff and community members who address critical societal issues.

Uncategorized Portrait of the researchers standing outside in front of a grove of trees.

Study links influenza A viral infection to microbiome, brain gene expression changes

CHAMPAIGN, Ill. — In a study of newborn piglets, infection with influenza A was associated with disruptions in the piglets’ nasal and gut microbiomes and with potentially detrimental changes in gene activity in the hippocampus, a brain structure that plays a central role in learning and memory. Maternal vaccination against the virus during pregnancy appeared […]

Strategic Communications and Marketing News Bureau

507 E. Green St
MC-426
Champaign, IL 61820

Email: stratcom@illinois.edu

Phone (217) 333-5010